Cargando…
Long non-coding RNA receptor activator of nuclear factor-κ B ligand promotes cisplatin resistance in non-small cell lung cancer cells
Non-small cell lung cancer (NSCLC) is a common malignancy associated with poor clinical outcomes and high mortality rate. The association between NSCLC development and long non-coding RNA (lncRNA) expression remains to be elucidated. The current study investigated the role of a novel lncRNA, recepto...
Autores principales: | Zhu, Zhongcheng, Gong, Xiaoyi, Li, Jing, Shi, Yufeng, Zhang, Mingyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014969/ https://www.ncbi.nlm.nih.gov/pubmed/33815591 http://dx.doi.org/10.3892/etm.2021.9949 |
Ejemplares similares
-
A Novel Long Non-coding RNA, MSTRG.51053.2 Regulates Cisplatin Resistance by Sponging the miR-432-5p in Non-small Cell Lung Cancer Cells
por: Zhang, Jie, et al.
Publicado: (2020) -
Long non‐coding RNAs: How to regulate the metastasis of non–small‐cell lung cancer
por: Fang, Cheng, et al.
Publicado: (2020) -
Emerging role of long non-coding RNAs in cisplatin resistance
por: Hu, Yang, et al.
Publicado: (2018) -
Long non-coding RNA AL137789.1 promoted malignant biological behaviors and immune escape of pancreatic carcinoma cells
por: Wang, Jing, et al.
Publicado: (2023) -
Comparison of liposomal cisplatin versus cisplatin in non-squamous cell non-small-cell lung cancer
por: Stathopoulos, G. P., et al.
Publicado: (2011)